Viewing Study NCT06647368



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06647368
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-14

Brief Title: Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans
Sponsor: None
Organization: None

Study Overview

Official Title: Investigating the Effect of Glucagon on Cognitive Function and Cerebral Glucose Metabolism in Humans A Pilot study_A
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the study is to develop a non-invasive method for quantifying cerebral glucose metabolism by PET scans in humans This method will be used in subsequent studies where the effect of the pancreatic hormone glucagon on cerebral glucose metabolism will be studied

The golden standard for quantifying cerebral glucose metabolism by PET scans is based on arterial blood sampling which complicates research setup This study will investigate if image derived measurements instead of arterial blood samples can be used to quantify cerebral glucose metabolism

We will compare the calculations of cerebral glucose metabolism based on arterial blood samples and image derived measurements and hopefully these will correlate

Healthy participants will be included and each participant will participate in one study day which includes intravenous administration of radioactively labelled glucose 18-FDG arterial blood sampling and PET scans
Detailed Description: Participants will arrive after a four hour fast An arterial cannulation will be placed in the radial or brachial artery for blood sampling A venous catheter will be placed in the antecubital vein for administration of 18-FDG Blood glucose is measured

Before administration of 18-FDG a low dose CT scan of the heart and brain will be performed

At time 0 minutes 20 MBq 18-FDG will be administered 10 minutes automatic blood sampling from the arterial cannulation will be started and a 10 minutes three part dynamic PET scan of the heart will be performed

Approximately at time 20 minutes 180 MBq 18-FDG will be administered and a 40 minutes three part dynamic PET scan of the brain will be performed During the first 10 minutes of the brain scan automatic blood sampling from the arterial cannulation will be performed and thereafter manual blood sampling will be performed every 5 minutes

After the 40 minutes brain PET scan a 5 min post scan of the heart will be performed

Radioactivity will be measured in the arterial blood samples and the results will be used for an Arterial Input Function AIF

Radioactivity measurements derived from the heart scans will be used for an Image Derived Input Function IDIF

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None